Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.

De Vroey B, Moreno C, Laleman W, van Gossum M, Colle I, de Galocsy C, Langlet P, Robaeys G, Orlent H, Michielsen P, Delwaide J, Reynaert H, D'Heygere F, Sprengers D, Bourgeois S, Assene C, Vos B, Brenard R, Adler M, Henrion J, Deltenre P.

Eur J Gastroenterol Hepatol. 2013 May;25(5):613-9. doi: 10.1097/MEG.0b013e32835d83a2.

PMID:
23325285
2.

Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.

Hartleb M, Gutkowski K, Zejda JE, Chudek J, Więcek A.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1288-95.

PMID:
22864260
3.

A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.

Voiculescu M, Iliescu L, Ionescu C, Micu L, Ismail G, Zilisteanu D, Radasan A, Micu G, Pertache I.

J Gastrointestin Liver Dis. 2010 Mar;19(1):43-8.

4.

Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.

Nguyen LH, Ko S, Wong SS, Tran PS, Trinh HN, Garcia RT, Ahmed A, Lutchman GA, Keeffe EB, Nguyen MH.

Hepatology. 2011 Jun;53(6):1839-45. doi: 10.1002/hep.24308.

PMID:
21425314
5.

Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.

Ho E, Deltenre P, Nkuize M, Delwaide J, Colle I, Michielsen P; Belgian Association for the Study of the Liver.

J Med Virol. 2013 Sep;85(9):1513-7. doi: 10.1002/jmv.23653.

PMID:
23852675
6.

Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses.

Guptan RC, Thakur V, Raina V, Sarin SK.

J Gastroenterol Hepatol. 1999 Sep;14(9):893-8.

PMID:
10535471
7.

Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.

Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P.

J Med Virol. 1997 Apr;51(4):313-8.

PMID:
9093946
8.

Diagnostic incidence of the presence of positive HBsAg: epidemiologic, clinical, and virological characteristics.

Poves-Martínez E, del Pozo-Prieto D, Costero-Pastor B, Borrego-Rodríguez G, Beceiro-Pedroño I, Sanz-García C, Busteros-Buraza JI, González Palacios MR.

Rev Esp Enferm Dig. 2012 Feb;104(1):10-5. English, Spanish.

PMID:
22300111
9.

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.

Chen LW, Chien RN, Yen CL, Chang JJ, Liu CJ, Lin CL.

J Gastroenterol Hepatol. 2010 Feb;25(2):259-63. doi: 10.1111/j.1440-1746.2009.06006.x. Epub 2009 Oct 9.

PMID:
19817959
10.

[Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].

Fabrizi F, Bisegna S, Mangano S, Alongi G, Colucci P, Finazzi S, De Vecchi AF, Ponticelli C.

G Ital Nefrol. 2002 Mar-Apr;19(2):149-54. Italian.

PMID:
12195413
11.

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.

Ferraro D, Bonura C, Giglio M, Di Stefano R, Almasio PL, Di Marco V, Craxì A, Cacciola I, Squadrito G, Raimondo G.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5.

PMID:
14518718
12.

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P.

Ann Hepatol. 2008 Apr-Jun;7(2):152-6.

PMID:
18626434
13.

Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.

Kaya S, Cetin ES, Aridogan BC, Arikan S, Demirci M.

J Microbiol Immunol Infect. 2007 Aug;40(4):288-92.

PMID:
17712462
14.

Clinical features and outcome of chronic viral hepatitis with acute exacerbation in patients with concurrent infections of hepatitis B and C virus.

Chuang CS, Tung SY, Lee IL, Shen CH, Wei KL, Chang TS, Wu CS.

Dig Dis Sci. 2008 Feb;53(2):511-6. Epub 2007 Aug 9.

PMID:
17682944
15.

Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.

Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, Trabaud MA, Chevallier P, Chevallier M, Zoulim F, Trépo C.

J Med Virol. 2007 Aug;79(8):1075-81.

PMID:
17596829
16.

High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.

Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.

HIV Med. 2010 Jan;11(1):85-9. doi: 10.1111/j.1468-1293.2009.00742.x. Epub 2009 Jul 29.

17.

Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: prevalence and clinical significance.

Cardoso C, Alves AL, Augusto F, Freire R, Quintana C, Gonçalves M, Oliveira AP.

Eur J Gastroenterol Hepatol. 2013 Feb;25(2):142-6. doi: 10.1097/MEG.0b013e328359fe54.

PMID:
23044809
18.

Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.

Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF.

J Gastroenterol Hepatol. 2010 Jan;25(1):101-6. doi: 10.1111/j.1440-1746.2009.05972.x. Epub 2009 Oct 9.

PMID:
19817965
19.

Major risk of blood transfusion in hemolytic anemia patients.

Omar N, Salama K, Adolf S, El-Saeed GS, Abdel Ghaffar N, Ezzat N.

Blood Coagul Fibrinolysis. 2011 Jun;22(4):280-4. doi: 10.1097/MBC.0b013e3283451255.

PMID:
21508832
20.

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections.

Mathurin P, Thibault V, Kadidja K, Ganne-Carrié N, Moussalli J, El Younsi M, Di Martino V, Lunel F, Charlotte F, Vidaud M, Opolon P, Poynard T.

J Viral Hepat. 2000 Jan;7(1):15-22.

PMID:
10718938
Items per page

Supplemental Content

Write to the Help Desk